FRI0506 EFFICACY AND SAFETY OF CANAKINUMAB IN ADULT-ONSET STILL'S DISEASE: A SINGLE-CENTER REAL-LIFE EXPERIENCE
Alessandro Tomelleri, Corrado Campochiaro, Giacomo De Luca, Nicola Farina, Elena Baldissera, Giulio Cavalli, Lorenzo Dagna
Topics & Concepts
MedicineAnakinraCanakinumabTocilizumabAdverse effectInternal medicineDiscontinuationCohortConcomitantAdult-onset Still's diseasePediatricsSurgeryDiseaseAutoimmune and Inflammatory Disorders ResearchOtitis Media and Relapsing PolychondritisImmune Cell Function and Interaction